CClinicalTrials.gg
RecruitingNCT07820293Updated Sep 15, 2026

Comparative Effect of Instrument-Assisted Soft Tissue Mobilization and Deep Transverse Friction Massage in Patients With Trapezius Myalgia

An interventional study of Deep Transverse Friction Massage (DTFM) and Instrument-Assisted Soft Tissue Mobilization (IASTM) in Trapezius Myalgia, sponsored by Ibadat International University, Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Ibadat International University, Islamabad · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This randomized controlled trial compares the effectiveness of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Deep Transverse Friction Massage (DTFM) in patients with trapezius myalgia. A total of 42 participants aged 18-45 years will be randomly assigned to either intervention group. Both groups will also receive conventional physiotherapy consisting of TENS, hot packs, range-of-motion exercises, and stretching. Treatment will be provided four sessions per week for four weeks. Outcomes include pain intensity, cervical range of motion, muscle strength, and functional disability.

Read the detailed description

Trapezius myalgia is a common musculoskeletal disorder characterized by pain, muscle tightness, stiffness, fatigue, and reduced cervical movement. It commonly develops due to poor posture, prolonged desk work, repetitive upper-limb activities, and occupational stress. These symptoms reduce functional ability and quality of life.

Although both Instrument-Assisted Soft Tissue Mobilization (IASTM) and Deep Transverse Friction Massage (DTFM) are widely used in physiotherapy, evidence comparing their effectiveness is limited. Therefore, this study aims to determine which intervention provides greater improvements in pain, cervical range of motion, muscle strength, and functional disability.

The study will be conducted as a randomized controlled trial at the Department of Physical Therapy, Ibadat International University Islamabad. Forty-two participants will be recruited using a sample size calculated through OpenEpi. Eligible participants will be randomly allocated into two intervention groups.

Both groups will receive conventional physiotherapy consisting of Transcutaneous Electrical Nerve Stimulation (TENS), hot pack application, active range-of-motion exercises, and stretching exercises. Treatment will be administered four sessions per week for four weeks (16 sessions).

The DTFM group will receive manual deep transverse friction massage over the upper trapezius muscle to reduce pain, release adhesions, and improve tissue mobility. The IASTM group will receive soft tissue mobilization using stainless-steel instruments to improve circulation, release fascial restrictions, and promote tissue healing.

Outcome measures will include the Numeric Pain Rating Scale (NPRS), Bubble Inclinometer for cervical range of motion, Hand-Held Dynamometer for muscle strength, and Neck Disability Index (NDI). Data will be analyzed using SPSS version 25 with appropriate parametric or non-parametric statistical tests. Statistical significance will be set at p ≤ 0.05.

The findings will contribute to evidence-based physiotherapy practice by identifying the more effective manual therapy technique for treating trapezius myalgia.

02

Conditions studied

  • Trapezius Myalgia

Keywords

  • Instrument-Assisted Soft Tissue Mobilization
  • Deep Transverse Friction
  • Trapezius Myalgia
03

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male and female participants aged 18-45 years. Clinical diagnosis of trapezius myalgia with neck pain lasting more than two weeks.

Tenderness over the upper trapezius muscle. NPRS pain score greater than 4. Cervical flexion less than 60° and extension less than 50°. Able to understand the study procedures and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Congenital or structural musculoskeletal deformities (e.g., torticollis, scoliosis, cervical rib).

Open wounds, skin infections, or dermatological conditions over the treatment area.

Cervical spine or upper limb surgery within the previous 12 months. Cervical radiculopathy, cervical spondylosis, herniated disc, or whiplash injury.

04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Deep Transverse Friction Massage (DTFM)

    Participants will receive Deep Transverse Friction Massage over the upper trapezius muscle along with conventional physiotherapy, including TENS, hot packs, stretching, and active range-of-motion exercises. The intervention aims to reduce pain, improve tissue mobility, increase cervical range of motion, enhance muscle strength, and improve functional ability

    Other: Deep Transverse Friction Massage (DTFM)

  • Active comparator
    Instrument-Assisted Soft Tissue Mobilization (IASTM)

    Participants will receive Instrument-Assisted Soft Tissue Mobilization using stainless-steel instruments together with the same conventional physiotherapy protocol. The intervention aims to reduce soft tissue restrictions, improve circulation, decrease pain, enhance cervical mobility, increase muscle strength, and improve functional outcomes.

    Other: Instrument-Assisted Soft Tissue Mobilization (IASTM)

Interventions

  • OtherDeep Transverse Friction Massage (DTFM)

    Participants will receive Deep Transverse Friction Massage over the upper trapezius muscle along with conventional physiotherapy, including TENS, hot packs, stretching, and active range-of-motion exercises. The intervention aims to reduce pain, improve tissue mobility, increase cervical range of motion, enhance muscle strength, and improve functional ability.

  • OtherInstrument-Assisted Soft Tissue Mobilization (IASTM)

    Participants will receive Instrument-Assisted Soft Tissue Mobilization using stainless-steel instruments together with the same conventional physiotherapy protocol. The intervention aims to reduce soft tissue restrictions, improve circulation, decrease pain, enhance cervical mobility, increase muscle strength, and improve functional outcomes

05

What researchers measure

Primary outcomes

  1. Bubble Inclinometer

    Cervical range of motion measured using a Bubble Inclinometer.

    Time frame: Baseline and after four weeks of treatment.

  2. Numeric Pain Rating Scale (NPRS).

    Pain intensity measured using the Numeric Pain Rating Scale (NPRS).

    Time frame: Baseline and after four weeks of treatment.

  3. Neck Disability Index (NDI).

    Functional disability assessed using the Neck Disability Index (NDI).

    Time frame: Baseline and after four weeks of treatment

Secondary outcomes

  1. Hand-Held Dynamometer.

    Muscle strength measured using a Hand-Held Dynamometer.

    Time frame: Baseline and after four weeks of treatment.

06

Study locations

1 of 1 sites recruiting
  • Ibadat International University, Islamabad (Iiui)
    Islamabad, 46000, Pakistan
    • Hafsah Arshad, PhD* · Contact · hafsaharshad12@gmail.com · 03315165234
    • Naheed Akhter, Masters · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07820293
Lead sponsor
Ibadat International University, Islamabad
Responsible party
Hafsah Arshad (Assistant Professor, Ibadat International University, Islamabad) — Principal investigator
First posted
Sep 15, 2026
Start date
Mar 7, 2026
Primary completion
Sep 28, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Sep 15, 2026

Study contacts

Hafsah Arshad, PhD*
Contact
hafsaharshad12@gmail.com
03315165234
Naheed Akhtar, Masters
Contact
hibaraja078@gmail.com

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion